1. Home
  2. NOTE vs PMN Comparison

NOTE vs PMN Comparison

Compare NOTE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.62

Market Cap

24.7M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.25

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTE
PMN
Founded
2013
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.7M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NOTE
PMN
Price
$1.62
$8.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$29.25
$72.67
AVG Volume (30 Days)
281.3K
15.6K
Earning Date
03-12-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,673,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$6.27
52 Week High
$24.36
$39.75

Technical Indicators

Market Signals
Indicator
NOTE
PMN
Relative Strength Index (RSI) 44.55 64.61
Support Level $1.46 $8.08
Resistance Level $1.79 $8.51
Average True Range (ATR) 0.15 0.43
MACD 0.04 -0.12
Stochastic Oscillator 59.52 84.06

Price Performance

Historical Comparison
NOTE
PMN

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: